An Open-Label Study to Assess the Effect of Cimetidine on the Pharmacokinetics of Dexpramipexole (BIIB050) in Healthy Volunteers is a PHASE1 clinical asset sponsored by Knopp Biosciences in Amyotrophic Lateral Sclerosis. SEO and diligence focus: Dexpramipexole, Cimetidine plus Dexpramipexole, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.